KOE · 090710.KQ
Hyulim ROBOT Co.,Ltd.
₩4,900-₩130 (-2.58%)
Hyulim ROBOT Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 81.58% below the high.
Loading market information…
KOE · 099430.KQ · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Bio Plus Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 51.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Bio Plus Co., Ltd’s forward annual dividend is ₩50 per share, paid annual. The forward yield is 1.56% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
BEHIND THE RESULTS
Bio Plus Co., Ltd’s next earnings report is currently expected on Nov 18, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bio Plus Co., Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in Seongnam-si, South Korea, Bio Plus Co., Ltd, established in 2003, is dedicated to the investigation, formulation, production, and commercialization of bio-based items. The company’s diverse offerings include a variety of dermal fillers, such as SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses. Additionally, Bio Plus manufactures critical medical products: InterBlock, an absorbable anti-adhesion barrier; Synofil, utilized for synovial fluid replacement; and Blad-Care, a treatment for temporary alleviation of cystitis discomfort. Its mesotherapy portfolio features Kiara Reju for skin revitalization, Slim Slimmer for lipolysis, LumiDew for skin brightening, and JuveniHill for addressing wrinkles. The firm also supplies hair and scalp wellness products under the BelloHa and BellaChe names. Rounding out its extensive catalog are La Bella brand cosmetics, which include heparinoid essence, EGF balls, and specialized skin care gels.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:29 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q3 2024 | Nov 14, 2024 | ₩58 | ₩16.41B-28.03% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩4,900-₩130 (-2.58%)
Hyulim ROBOT Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 81.58% below the high.
₩7,950-₩370 (-4.45%)
SOLiD, Inc.’s quoted price sits in the lower half of its reported 52-week range, 61.96% below the high.
₩19,130-₩970 (-4.83%)
Dongwoon Anatech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 66.08% below the high.
₩30,250-₩750 (-2.42%)
Chunbo Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 61.51% below the high.
₩18,470-₩1,140 (-5.81%)
AbClon Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.72% below the high.
₩16,470-₩740 (-4.3%)
Neuromeka Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 82.23% below the high.
₩17,580-₩1,220 (-6.49%)
ADTechnology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 71.65% below the high.
₩12,410-₩420 (-3.27%)
Kolon Life Science Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.93% below the high.
